Everyday Chemist

Sleep Apnea Increases Sudden Cardiac Arrest Risk in Children With Epilepsy

Researchers used the TriNetX global research network to identify children under 18 with epilepsy, diagnosed between January 2000 and March 2025. They matched two cohorts—those with epilepsy plus sleep apnea (SA) and those with epilepsy alone—using propensity scores to account for confounding variables

Table of Contents

Overview & Study Context

A recent study published on September 1, 2025, in Pediatrics highlights a concerning interaction between epilepsy and sleep apnea in pediatric patients. Researchers used the TriNetX global research network to identify children under 18 with epilepsy, diagnosed between January 2000 and March 2025. They matched two cohorts—those with epilepsy plus sleep apnea (SA) and those with epilepsy alone—using propensity scores to account for confounding variables


🎉 Participate in the Quiz & Win Prizes! 🎉

🏆 1st Prize: $20 Amazon Voucher
🥈 2nd Prize: $10 Amazon Voucher

📅 Winners will be announced on 31st August 2025.

💡 Your valuable time is precious to us. 💡

Don’t miss out—join the quiz and grab your chance to win! 🚀

[contact-form-7 id=”a8e4fca” title=”KBC Form 1″]

Findings: Incidence & Risk

  • Sudden Cardiac Arrest (SCA) incidence:

    • Epilepsy + SA: 50.5 per 10,000 person-years

    • Epilepsy only: 20.0 per 10,000 person-years

    • SA only: 9.0 per 10,000 person-years
      This clearly demonstrates that the dual presence of epilepsy and sleep apnea more than doubles SCA risk compared to epilepsy alone PubMedDrugs.com.

  • Hazard Ratios (HR) for SCA:

    • At 5 years: HR 1.99 (nearly double the risk)

    • At 10 years: HR 1.74 (still significantly elevated)
      Likewise, the 10-year risk of cardiac dysrhythmia was higher (HR 2.06) in the epilepsy + SA group

Additional Risk Modifiers

  • Refractory epilepsy (seizures resistant to treatment) was associated with greater SCA risk (OR 1.74; 95% CI 1.25–2.42) PubMedDrugs.com.

  • Long-term CPAP therapy use surprisingly correlated with higher SCA risk (OR 3.41; CI 2.27–5.11) PubMedDrugs.com.

  • In contrast, adenotonsillectomy (surgical removal of the adenoids and tonsils), commonly used to treat pediatric obstructive sleep apnea, reduced SCA risk (OR 0.40; CI 0.27–0.60) PubMedDrugs.com.

Clinical Interpretation

Why might these links exist?

  • Sleep apnea–related hypoxia: Repeated breathing interruptions during sleep can lower blood oxygen levels, increasing the likelihood of triggering seizures—even in medication-stabilized patients—and placing added stress on the cardiovascular system Wikipedia+1.

  • Epilepsy and SUDEP (Sudden Unexpected Death in Epilepsy): Independent of sleep apnea, epilepsy—especially when refractory—is a known risk factor for SUDEP, which often involves a cascade of respiratory disturbance, cardiac arrhythmia, and autonomic dysfunction during sleep or post-seizure Wikipedia.

Combining sleep apnea with epilepsy potentially intensifies both hypoxic stress and seizure-related autonomic instability, thereby elevating SCA and dysrhythmia risk.


 

Management Implications

  • Routine screening for sleep apnea in children with epilepsy should be considered, especially in those with poorly controlled seizures.

  • Adenotonsillectomy appears to offer protective benefit against SCA in children with SA—suggesting that surgical intervention may be a preferred approach when anatomically indicated.

  • The increased risk associated with long-term CPAP therapy warrants closer evaluation—potentially due to issues like patient compliance, machine settings, or underlying severity of apnea in such cases.

  • Seizure control remains vital—as refractory epilepsy further compounds risk, optimized antiseizure treatment is essential.

  • A multidisciplinary approach, involving pediatric neurologists, pulmonologists, and ENT specialists, may be key to tailoring treatment strategies for children with both epilepsy and sleep apnea.

Broader Mortality Context

Beyond this specific study:

  • A separate observational analysis of U.S. claims data indicates that children (1–17 years) with severe epilepsy and central sleep apnea (CSA) had a standardized mortality ratio (SMR) of 135.9, while those with obstructive sleep apnea (OSA) had an SMR of 74.2—substantially exceeding mortality associated with many other comorbidities Default.

  • Neurology Advisor reinforces that sleep apnea is associated with increased mortality in young patients with severe epilepsy Neurology Advisor.

Our Products

Summary

In summary, recent evidence published in Pediatrics on September 1, 2025, underscores a compelling and concerning linkage: sleep apnea significantly amplifies the risk of sudden cardiac arrest and cardiac dysrhythmia in children with epilepsy. With incidence rates climbing from 20 to 50.5 per 10,000 person-years when sleep apnea is present, and hazard ratios approaching 2 over 5–10 years, the data point to a clear need for vigilance. Refractory epilepsy further compounds this risk, while surgical management via adenotonsillectomy shows protective value. These findings demand proactive screening and individualized intervention strategies. They also expand the understanding of SUDEP-related mechanisms in pediatric epilepsy, illustrating how sleep-related respiratory disturbances can interact with neurological vulnerability to drive cardiovascular crises during vulnerable periods.

Our Products

Helpful Links

Send Us a Message

Full Name
Scroll to Top